肿瘤化疗所致恶心呕吐现状调查课件.pdfVIP

• 2013, 13(6): 687691 * 430030 chemotherapy-induced nausea and vomitingCINV CINV CINV MEC HEC2 6 CINV 344 303 MEC 86.1%76.6% 71.5%HEC 84.1%71.0% 66.7% 93.8%64.9% 64.9% 2 30% CINV CINV CINV Status Survey on Chemotherapy-Induced Nausea and Vomiting DONG Shuang, YU Shi-ying* Tongji Hospital Ailiated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430030, China Abstract Objective To investigate the patient’s psychological anticipation and occurrence of chemotherapy- induced nausea and vomiting (CINV), and to assess the inl uence of CINV on quality of life, so as to provide evidence for clinical doctors to recognize and pay attention to CINV. Methods h e patients in the Tongji Hospital ailiated to Tongji Medical College of Huazhong University of Science and Technology who took either moderately emetogenic chemo- therapy (MEC) or highly emetogenic chemotherapy (HEC) were randomly sampled with a questionnaire for two circles. Patients were asked to record the following indexes before chemotherapy, on the second day and the sixth day of chemo- therapy: acute and delayed nausea and vomiting, independently taking antiemetics, and functional living index-emesis (FLIE). h en, descriptive analysis and multiple linear regression analysis were adopted for the outcomes of investigation. Results A total of 344 patients were investigated, of which 303 fulfilled the questionnaire finally. For the single-day chemotherapy, the acute nausea and vomiting, delayed nausea vomiting and overall complete remission in the MEC group were 86.1%, 76.6%, and 71.5%, respectively; while those of the HEC group were 84.1%, 71.0%, and 66.7%, respectively. For the multi-day c